Genetics of Epstein-Barr virus infection

Biomedicine and Pharmacotherapy

Volumn 55, Issue 7, 2001, Pages 369-372

  Hiraki, A ^a   Fujii, N ^a   Masuda, K ^a   Ikeda, K ^a   Tanimoto, M ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Epstein Barr virus; Immune response; Latent infection; Replication

Indexed keywords

ALPHA INTERFERON; B LYMPHOCYTE RECEPTOR; CD23 ANTIGEN; CD40 ANTIGEN; CELL ADHESION MOLECULE; COLONY STIMULATING FACTOR 1; EPSTEIN BARR VIRUS ANTIGEN; GAMMA INTERFERON; LATENT MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NUCLEAR FACTOR; PROTEIN C JUN; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR; VIRUS RNA;

BURKITT LYMPHOMA; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HERPES VIRUS; HODGKIN DISEASE; HUMAN; IMMUNE RESPONSE; INFECTIOUS MONONUCLEOSIS; LYMPHOEPITHELIOMA; LYMPHOPROLIFERATIVE DISEASE; MUSCLE TUMOR; NASOPHARYNX CARCINOMA; NONHODGKIN LYMPHOMA; PATHOPHYSIOLOGY; PLEURA EMPYEMA; PRIORITY JOURNAL; REVIEW; STOMACH CARCINOMA; VIRAL GENETICS; VIRUS CARCINOGENESIS; VIRUS INFECTION; VIRUS REACTIVATION; VIRUS REPLICATION;

EID: 0034808110     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(01)00084-1     Document Type: Article

References (41)

1. Sarcoma involving the jaws in Africa children
2. Virus particles in cultured lymphoblasts from Burkitt's lymphoma
3. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis
4. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx
5. Outbreak of Burkitt's-like lymphoma in homosexual men
6. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion
7. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections
8. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease
9. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction
10. Epstein-Barr virus-associated gastric adenocarcinoma
11. Epstein-Barr virus in pyothorax-associated pleural lymphoma
12. High expression of the Epstein-Barr virus latent protein EB nuclear antigen on pyothorax-associated lymphoma
13. Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS
14. Epstein-Barr virus receptor of human B lymphocytes in the C3d receptor CR2
15. Epstein-Barr virus and its replication
16. Replication of Epstein-Barr virus in human epithelial cells infected in vitro
17. A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals
18. Epstein-Barr virus replication in oropharyngeal epithelial cells
19. Role of epithelium in EBV persistence and pathogenesis of B-cell tumours
20. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: Implications for the interindividual infection route of Epstein-Barr virus
21. Epstein-Barr virus (EBV) infection in infectious mononucleosis: Virus latency, replication and phenotype of EBV-infected cells
22. Epstein-Barr virus
23. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1
24. Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells
25. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1
26. Vaccine strategies against Epstein-Barr virus-associated diseases: Lessons from studies on cytotoxic T-cell-mediated immune regulation
27. EBV persistence in memory B cells in vivo
28. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders
29. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells
30. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1
31. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23
32. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
33. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice
34. Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses
35. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family
36. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients
37. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases
38. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals
39. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata
40. Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: Cell phenotype dependence of viral promoter usage
41. Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state